UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 22, 2012
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
Delaware | 001-14057 | 61-1323993 | ||
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
680 South Fourth Street Louisville, Kentucky |
40202-2412 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (502) 596-7300
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Item 5.02(b)
On February 22, 2012, Ms. Ann C. Berzin notified the Board of Directors (the Board) of Kindred Healthcare, Inc. (the Company) that she will not stand for re-election to the Board at the Companys 2012 annual meeting of shareholders. Ms. Berzins term on the Board will expire upon the conclusion of the Companys 2012 annual meeting of shareholders.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereto duly authorized.
Date: February 23, 2012 | By: | /s/ Joseph L. Landenwich | ||||
Joseph L. Landenwich | ||||||
Senior Vice President, Corporate Legal Affairs and Corporate Secretary |